Company Filing History:
1 out of 155 
1 out of 4 Years Active: 2014
Title: Ahmed Hassan Amin Abdelazeem: Innovator in Sigma Receptor Ligands
Introduction
Ahmed Hassan Amin Abdelazeem is a notable inventor based in Oxford, MS (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of highly selective sigma receptor ligands. His innovative work has implications for various therapeutic applications.
Latest Patents
Abdelazeem holds a patent for "Highly selective sigma receptor ligands." This patent describes compounds characterized by a complex general formula that includes various radicals and moieties. The compounds are designed to exhibit specific interactions with sigma receptors, which are important in pharmacology. His patent includes 1 patent that outlines the structural diversity and potential applications of these ligands.
Career Highlights
Throughout his career, Abdelazeem has worked with esteemed institutions such as the University of Mississippi and Université Catholique de Louvain. His research has focused on the synthesis and characterization of novel compounds that can lead to advancements in drug development.
Collaborations
Abdelazeem has collaborated with notable colleagues, including Christopher R. McCurdy and Christophe Mesangeau. These collaborations have enriched his research and contributed to the advancement of knowledge in the field of sigma receptor ligands.
Conclusion
Ahmed Hassan Amin Abdelazeem is a distinguished inventor whose work in sigma receptor ligands showcases his innovative spirit and dedication to advancing medicinal chemistry. His contributions are valuable to the scientific community and have the potential to impact therapeutic development significantly.